Twelve of 14 (86%) patients with GATA2 deficiency were found to have a clinical indication, cytogenetic findings, and/or molecular findings warranting to proceed to allo-HSCT. The gene discussed is GATA2; the disease is hyperinsulinemic hypoglycemia, familial, 4.